Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink

被引：0
|
作者：
Suissa, Samy
Dell'Aniello, Sophie
Ernst, Pierre
机构：
[1] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
来源：
CHEST | 2020年 / 158卷 / 02期
关键词：
D O I：
10.1016/j.chest.2020.03.046
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：832 / 833
页数：2
相关论文
共 50 条
  • [21] Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 18 (01) : 1 - 8
  • [22] Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    LANCET RESPIRATORY MEDICINE, 2018, 6 (11): : 855 - 862
  • [23] Heterogeneous treatment effect estimation of LABA/LAMA/ICS on COPD exacerbation risk in the IMPACT trial
    Verstraete, Kenneth
    Gyselinck, Iwein
    Huts, Helene
    De Vos, Maarten
    Janssens, Wim
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [24] Cost-effectiveness of umeclidinium bromide 62.5μg or alternative LAMA plus ICS/LABA in COPD
    Driessen, Maurice
    Risebrough, Nancy
    Briggs, Andrew
    Ismaila, Afisi
    Shah, Dhvani
    Naya, Ian
    Baker, Timothy M.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [25] POTENTIAL SAVINGS ACHIEVED THROUGH SWITCHING COPD PATIENTS FROM ICS-CONTAINING REGIMENS TO LAMA-LABA: A DUTCH PERSPECTIVE
    Fens, T.
    Postma, M. J.
    Voorhaar, M.
    Soulard, S.
    Baldwin, L.
    VALUE IN HEALTH, 2017, 20 (09) : A650 - A650
  • [26] Assessment of efficacy and tolerability of roflumilast add-on to LABA/LAMA/ICS in the treatment of COPD in Indian patients
    Mandke, Kshitij
    Mandke, Anup
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [27] FACTORS INFLUENCING STEP-UP TO LAMA plus LABA/ICS IN COPD PATIENTS INITIALLY ON LAMA MONOTHERAPY: A THIN DATABASE STUDY
    Hurst, J. R.
    Dilleen, M.
    Morris, K.
    Hills, S.
    Emir, B.
    Jones, R.
    THORAX, 2016, 71 : A116 - A116
  • [28] Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study
    Bogart, Michael
    Stanford, Richard H.
    Reinsch, Tyler
    Hull, Michael
    Buikema, Ami
    Hulbert, Erin
    RESPIRATORY MEDICINE, 2018, 142 : 73 - 80
  • [29] Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA plus LAMA in asthma patients - TAILOR study
    Verhamme, K. M.
    De Ridder, M.
    Rijnbeek, P.
    Mosseveld, M.
    Pedersen, L.
    Marconi, E.
    Lapi, F.
    Tan, C.
    Delmestri, A.
    Prieto-Alhambra, D.
    Nudo, E.
    Brusselle, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [30] A Randomized, Noninferiority Trial Comparing ICS thorn LABA with ICS plus LABA plus LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study
    Park, So-Young
    Kim, Solmi
    Kim, Jung-Hyun
    Kim, Sae-Hoon
    Lee, Taehoon
    Yoon, Sun-Young
    Kim, Min-Hye
    Moon, Ji-Yong
    Yang, Min-Suk
    Jung, Jae-Woo
    Kim, Joo-Hee
    Choi, Jeong-Hee
    Park, Chan Sun
    Kim, Sujeong
    Lee, Jaechun
    Kwon, Jae-Woo
    Hur, Gyu Young
    Kim, Sang-Ha
    Kim, Hee-Kyoo
    Shin, Yoo Seob
    Kim, Sang-Hoon
    Nam, Young-Hee
    Jang, An-Soo
    Park, Seo Young
    Kim, Tae-Bum
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1304 - +
12345